Drug recall · December 5, 2012
Arranon recall
Why: Impurities/Degradation Products: Potential for drug related impurities to exceed the specification limits.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Arranon (nelarabine) Injection 5mg/mL, 50mL Vials, Rx only, For I.V. Infusion only, GlaxoSmith Kline, Research Triangle Park, NC 27709. Made in England, NDC 0007-4401-06
- Lots / codes
Lot # C536707 Exp 02/14, C538830 Exp.02/14, C533169 Exp. 02/14
- Quantity
- 1,319 vials
- Company
- GlaxoSmithKline, LLC., Zebulon, NC
- Distribution
- Nationwide
- Initiated
- October 8, 2012 · Voluntary: Firm initiated
- Classified
- November 27, 2012
- Reported
- December 5, 2012
- Ended
- September 11, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Nelarabine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.